TechCrunch Podcast Covers BioticsAI's FDA Approval Path
TechCrunch's Build Mode podcast featured BioticsAI CEO Robhy Bustami discussing the company's journey from a $100,000 prototype to FDA clearance. The episode, released on April 30, 2026, covers challenges in medtech startups. Related events include TechCrunch Disrupt 2026 and a StrictlyVC gathering in San Francisco.
app.buzzsumo.comTechCrunch released a new episode of its Build Mode podcast on April 30, 2026, featuring Robhy Bustami, co-founder and CEO of BioticsAI. The episode, hosted by Isabelle Johannessen, explores BioticsAI's path to FDA clearance for its AI copilot designed to detect fetal abnormalities via ultrasound.
@techcrunch reported that the discussion highlighted maintaining team momentum during the uncertain FDA approval process.
BioticsAI, which won the Startup Battlefield at TechCrunch Disrupt 2023, began with a $100,000 prototype. Bustami shared insights on navigating regulations in the medtech industry, where rapid iteration is limited and milestones require extensive coordination.
The conversation emphasized the importance of cross-functional collaboration among engineers, clinicians and researchers, as well as finding investors attuned to the sector's high risks and slower timelines.
Isabelle Johannessen, head of the Startup Battlefield Program at TechCrunch, hosted the episode. She holds a master’s degree in Entrepreneurship & Disruptive Innovation and previously led international startup acceleration programs in Japan, Korea, Italy and Spain. Johannessen scouts early-stage companies across more than 99 countries, preparing them to pitch at Disrupt events.
The episode was produced and edited by Maggie Nye, a senior audio producer for TechCrunch based in Denver, Colorado. Nye previously served as brand and content manager for BUILT BY GIRLS and holds a bachelor’s degree in Journalism with a minor in English from Hofstra University in New York. Audience development for the podcast was led by Morgan Little.
Build Mode podcast episodes drop every Thursday, according to @techcrunch. The series focuses on startup building, with recent episodes including discussions on hiring practices, materials for space applications and approaches to layoffs. In this installment, Bustami addressed staying motivated when FDA approval is not guaranteed and the value of active industry advisors over prominent names.
TechCrunch is seeking applications for its Startup Battlefield, targeting early-stage companies with a minimum viable product. Founders can nominate themselves or others, mentioning the Build Mode podcast. The program connects participants with investors and media.
TechCrunch Disrupt 2026 is scheduled for October 13 to 15 in San Francisco. The event features the Startup Battlefield 200, where companies pitch on stage. Attendees can use the code 'buildmode15' for 15% off tickets, allowing access to networking with founders, venture capitalists and tech enthusiasts.
Separately, the StrictlyVC event is set for April 30 in San Francisco, California. It includes fireside chats and insights from leaders at companies such as Uber, Replit and Eclipse. Tickets are limited for the gathering focused on venture capital discussions.
Key Facts
Story Timeline
6 events- 2026-04-30
Build Mode podcast episode with Robhy Bustami of BioticsAI released.
1 source@techcrunch - 2026-04-30
StrictlyVC event scheduled in San Francisco, CA.
1 source@techcrunch - 2026-10-13 to 2026-10-15
TechCrunch Disrupt 2026 scheduled in San Francisco.
1 source@techcrunch - 2023
BioticsAI won the Startup Battlefield at TechCrunch Disrupt 2023.
1 source@techcrunch - Unspecified past
BioticsAI received FDA clearance.
1 source@techcrunch - Unspecified past
BioticsAI started with a $100,000 prototype.
1 source@techcrunch
Potential Impact
- 01
Promotion of TechCrunch Disrupt 2026 may boost attendance and startup applications.
- 02
StrictlyVC event could facilitate new VC connections for attendees.
- 03
Increased visibility for BioticsAI could attract more investors in medtech AI.
- 04
Discount code usage may increase ticket sales for Disrupt.
- 05
Insights from the podcast might influence other founders navigating FDA processes.
Transparency Panel
Related Stories
VarietyMajor Publishers and Author File Copyright Lawsuit Against Meta Over AI Training Data
Five major publishers and author Scott Turow filed a class-action lawsuit against Meta and CEO Mark Zuckerberg in Manhattan federal court, alleging illegal use of copyrighted books and articles to train the Llama AI model. The suit claims Zuckerberg personally authorized the infr…
naturalnews.comBrockman Testifies on Heated 2017 Dispute with Musk Over OpenAI's For-Profit Shift in Federal Trial
OpenAI President Greg Brockman detailed a heated 2017 confrontation with Elon Musk during testimony in the federal trial Musk v. Altman. He described Musk storming around a table and grabbing a painting after rejecting shared control proposals. The lawsuit seeks $150 billion in d…
Trump Administration Explores Government Review of AI Models Before Public Release
The Trump administration is discussing measures to vet advanced AI models for safety and security risks prior to their release, marking a potential shift from its previous hands-off stance on AI regulation. Officials are considering an executive order to establish a working group…